We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

Actym Therapeutics, a clinical-stage therapeutic product development and platform company, today announced the issuance of US patent Nos. 12,201,653 and 12,226,439 by the United States Patent and ...

Arizona's U.S. Sen. Ruben Gallego continues to reshape his image from that of a reliable liberal in the House to more of a ...

Food quality matters as much as diet type for heart health. Choosing whole, minimally processed foods can help lower heart ...

GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of ...

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...

Statisticians from the National University of Singapore (NUS) have developed a pioneering approach for analyzing ...

Discover the main causes behind eating disorders affecting millions. Learn about genetic, psychological and social factors ...

Sanofi faces setbacks after itepekimab’s Phase 3 COPD failure, removing a key growth prospect and highlighting reliance on ...

Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former ...